These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2956837)

  • 1. Influence of the methodology of percutaneous transluminal coronary angioplasty on restenosis.
    Douglas JS; King SB; Roubin GS
    Am J Cardiol; 1987 Jul; 60(3):29B-33B. PubMed ID: 2956837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of calcium entry blockers during and after percutaneous transluminal coronary artery angioplasty.
    Schlant RC; King SB
    Circulation; 1989 Dec; 80(6 Suppl):IV88-92. PubMed ID: 2688988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty.
    Cox JL; Gotlieb AI
    Can J Cardiol; 1988 May; 4(4):201-10. PubMed ID: 2456140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of balloon size on initial success, acute complications, and restenosis after percutaneous transluminal coronary angioplasty. A prospective randomized study.
    Roubin GS; Douglas JS; King SB; Lin SF; Hutchison N; Thomas RG; Gruentzig AR
    Circulation; 1988 Sep; 78(3):557-65. PubMed ID: 2970337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
    Barnathan ES; Schwartz JS; Taylor L; Laskey WK; Kleaveland JP; Kussmaul WG; Hirshfeld JW
    Circulation; 1987 Jul; 76(1):125-34. PubMed ID: 2954724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Frankfurt experience in restenosis after coronary angioplasty.
    Bussmann WD; Kaltenbach M; Kober G; Vallbracht C
    Am J Cardiol; 1987 Jul; 60(3):48B-49B. PubMed ID: 2956842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting recurrent restenosis after percutaneous transluminal coronary balloon angioplasty.
    Glazier JJ; Varricchione TR; Ryan TJ; Ruocco NA; Jacobs AK; Faxon DP
    Am J Cardiol; 1989 Apr; 63(13):902-5. PubMed ID: 2522728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
    N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of percutaneous transluminal coronary angioplasty in patients with variant angina and coexistent coronary stenosis refractory to maximal medical therapy.
    Leisch F; Herbinger W; Brücke P
    Clin Cardiol; 1984 Dec; 7(12):654-9. PubMed ID: 6239723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis and its determinants in first and repeat coronary angioplasty.
    Rapold HJ; David PR; Guiteras Val P; Mata AL; Crean PA; Bourassa MG
    Eur Heart J; 1987 Jun; 8(6):575-86. PubMed ID: 2957201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.
    Corcos T; David PR; Val PG; Renkin J; Dangoisse V; Rapold HG; Bourassa MG
    Am Heart J; 1985 May; 109(5 Pt 1):926-31. PubMed ID: 3158187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restenosis after percutaneous transluminal coronary angioplasty--anatomic and pathophysiological mechanisms. Strategies for prevention.
    Block PC
    Circulation; 1990 Mar; 81(3 Suppl):IV2-4. PubMed ID: 2407372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Okamoto S; Inden M; Setsuda M; Konishi T; Nakano T
    Am Heart J; 1992 Jun; 123(6):1439-44. PubMed ID: 1595521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of prolonged inflation on coronary restenosis after balloon angioplasty].
    Martínez Elbal L; Calvo Orbe L; Gómez Recio M; Romero Tejero C; Sobrino Daza N
    Rev Esp Cardiol; 1994 Dec; 47(12):811-8. PubMed ID: 7855376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT).
    Albiero R; Silber S; Di Mario C; Cernigliaro C; Battaglia S; Reimers B; Frasheri A; Klauss V; Auge JM; Rubartelli P; Morice MC; Cremonesi A; Schofer J; Bortone A; Colombo A;
    J Am Coll Cardiol; 2004 Mar; 43(6):943-9. PubMed ID: 15028348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous transluminal coronary angioplasty restenosis: potential prevention with laser balloon angioplasty.
    Spears JR
    Am J Cardiol; 1987 Jul; 60(3):61B-64B. PubMed ID: 2956846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.
    Bourassa MG; Lespérance J; Eastwood C; Schwartz L; Côté G; Kazim F; Hudon G
    J Am Coll Cardiol; 1991 Aug; 18(2):368-76. PubMed ID: 1856404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rotational atherectomy and PTCA in complex coronary lesions (B2 and C): the immediate and long-term results].
    Isabella G; Ramondo A; Cardaioli P; Reimers B; Pasquetto G; Carasi M; Razzolini R; Chioin R
    G Ital Cardiol; 1995 Sep; 25(9):1127-38. PubMed ID: 8529849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.
    Parisi AF; Folland ED; Hartigan P
    N Engl J Med; 1992 Jan; 326(1):10-6. PubMed ID: 1345754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.